The state of New Jersey currently has 1 active clinical trials seeking participants for Type 1 Diabetes research studies. These trials are conducted in various cities, including New Brunswick, Hackensack, Newark and Morristown.
Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes
Recruiting
Type 1 diabetes (T1D) is a T cell-mediated autoimmune disease that causes a deficit of pancreatic islet beta cells. Millions of individuals worldwide have T1D, and incidence increases annually. Several recent clinical trials point to the need for an approach that produces comprehensive immune modulation at both the local pancreatic and systemic levels. Stem Cell Educator (SCE) therapy offers comprehensive immune modulation at both the local and systemic levels in T1D by using a patient's own imm... Read More
Gender:
ALL
Ages:
14 years and above
Trial Updated:
04/25/2024
Locations: Hackensack Meridian Health, Hackensack, New Jersey +1 locations
Conditions: Type 1 Diabetes